Overview

Locally Advanced Trial of Tri-weekly Metronomic Oral Vinorelbine and Cisplatin as Induction Therapy and Subsequent Concomitance With Radiation Therapy in Patients With Unresectable Non Small Cell Lung Cancer (NSCLC)

Status:
Completed

Trial end date:
2019-12-16

Target enrollment:

Participant gender:

Summary

Phase II clinical trial with metronomic oral vinorelbine and tri-weekly cisplatin as induction therapy and subsequent concomitantly with radiotherapy (RT) in patients with lung cancer (NSCLC) locally advanced unresectable

Phase:

Phase 2

Details

Lead Sponsor:

Spanish Lung Cancer Group

Treatments:

Cisplatin
Vinblastine
Vinorelbine